Mr. Dusit Chairat, Corporate Innovation Director of SCG, and Mr. Pisan Uawittaya, New Business Director of SCG Chemicals Public Company Limited (SCGC), attended the opening ceremony of IP Fair 2023, the Intellectual Property Expo. The event, held under the theme "IP Galaxy: A Universe of Ideas Driving the Economy with Intellectual Property," was presided over by Mr. Wutthikrai Leeveeraphan, Director-General of the Department of Intellectual Property. SCG showcased seven products and solutions across its diverse businesses, spanning health and medical innovations, innovations for better living, and advancements in artificial intelligence (AI). These innovative offerings are designed to cater to consumer needs and enhance quality of life.
SCG places a significant emphasis on intellectual property as a pivotal tool for fostering innovation. Intellectual property is a valuable asset warranting protection against unauthorized use or dissemination. This stance is coupled with a commitment to respect and uphold the intellectual property rights of others. Notably, SCG has successfully filed more than 2,500 patents for innovations, securing Exclusivity IP Rights. This accomplishment stems from a three-pronged strategy: idea generation (IP Creation), safeguarding (IP Protection), and enhancing business value (IP commercialization). These strategies collectively bolster the competitive edge and capacity of SCG to create innovative products and services aligned with consumer demands. SCGC underscores the significance of production, marketing, and sales in generating business revenue.
The MED SAFE system addresses the needs of closed-loop medication administration, facilitated by computer-prescribing physicians. Information directly transmitted from the physicians to the dispensing cart streamlines the process, with the cart featuring patient-specific drawers. These drawers are accessible through identity scanning, ensuring precise dispensing and minimizing human errors. The system also monitors drawer status, temperature, and humidity to maintain medications according to JCI standards, thereby preserving their quality for patients. MED SAFE's design is protected by product design patents and copyrights.
The VAROGARD mask incorporates HeiQ Viroblock from Switzerland into the melt-blown filter layer, effectively obstructing viruses and bacteria. Similarly, AC Filters coated with VAROGARD virus and bacteria inhibitors prevent virus and bacteria transmission through air conditioning systems. These innovations were developed by SCGC in response to the COVID-19 crisis, demonstrating the company's commitment to user safety and infection prevention. Rigorous testing, including SARs-CoV-2 inhibition tests from the Faculty of Medicine at Siriraj Hospital, bacterial inhibition assessments by NSTDA, and tissue non-toxicity evaluations by the Department of Medical Sciences, underscore the efficacy and safety of the coatings. Patent protection and trademark rights have been secured for these inventions.